Summary of GLP-1 Autoinjector and Medical Device Labeling Capabilities: Medium to high-speed labeling applications Label reconciliation & assurance labeling, never putting a bad label on a good product and eliminating the need for reworking unlabeled products Eliminating the need for pucks, no change parts required Proven, validated device labeling solutions Integration of RFID along with variable data printing and inspection Product inspection as well as label inspection Providing labeling solutions that meet market demands For More ProMach Pharma News, click here
Contact your BCBS affiliate directly and ask specifically about GLP-1 coverage for weight management indications under your current plan
We serve patients from Hollywood, Davie, Miami Gardens, Miramar, Pembroke Pines, and nearby communities
Liraglutida (Saxenda): en el ensayo SCALE, la prdida de peso media fue de 8,4 kg, lo que equivale al 8% del peso inicial, tras 56 semanas de tratamiento